1 Other causes are renal amyloidosis, syphilis, intercapillary glomerulosclerosis and renal-vein thrombosis. In children and young adults the syndrome occasionally develops in the absence of renal ...

It's not just a refreshing drink, but a powerful ally for brain and overall health. Its bioactive compounds enhance memory, ...

Park highlighted several applications of his work, including assays for measuring amyloid-β concentrations ... due to their intervention point within the haemostasis process. Thrombosis itself is a ...

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association ... perinatal cardiomyopathy and cardiac amyloidosis.3 37–39 Notably, the recommended duration for ...

Second, there exists no “amyloid cabal.” Many other features of Alzheimer’s have been researched over decades. Although my colleagues and I and many others have published extensively on the ...

But he implied that only misguided contrarians could dispute that lecanemab established the amyloid hypothesis as fact, and that such drugs would illuminate the path to solve the Alzheimer’s puzzle.

The results of a new brain imaging study led by researchers at Stony Brook Medicine indicates a link between WTC exposure duration and the presence of amyloid in the brain. Amyloid is a protein in ...

Amyloidosis occurs due to a buildup of amyloid proteins in the body. Along with treatment, complementary therapy can help with symptoms. Some examples include movements, such as yoga, sleep ...

Interv Cardiol. 2011;3(6):705-712. Altogether, the usefulness and merit of the contemporary thrombus grading classifications are widely accepted (Box 4). However, certain limitations should be ...

A speaker highlighted key advances in thrombosis and coronary disease treatment in 2024. Topics included updated European guidelines for DAPT after PCI and an upcoming trial marrying coronary CT ...

For decades, Alzheimer’s research has been shaped by the dominance of a single theory, the amyloid hypothesis. It holds that amyloid proteins prompt a cascade of biochemical changes in the brain ...

With the first amyloid-targeting drug now approved for Alzheimer’s disease, Alnylam has presented preliminary clinical results with a new candidate that could potentially be dosed as ...